Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.

Canine Diffuse Large B-cell Lymphoma (cDLBCL) is an aggressive cancer with variable clinical response. Despite recent attempts by gene expression profiling to identify the dog as a potential animal model for human DLBCL, this tumor remains biologically heterogeneous with no prognostic biomarkers to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Arianna Aricò, Serena Ferraresso, Silvia Bresolin, Laura Marconato, Stefano Comazzi, Geertruy Te Kronnie, Luca Aresu
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c69288cf336e43e3a27944a281b0616b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c69288cf336e43e3a27944a281b0616b
record_format dspace
spelling oai:doaj.org-article:c69288cf336e43e3a27944a281b0616b2021-11-25T05:54:33ZArray-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.1932-620310.1371/journal.pone.0111817https://doaj.org/article/c69288cf336e43e3a27944a281b0616b2014-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0111817https://doaj.org/toc/1932-6203Canine Diffuse Large B-cell Lymphoma (cDLBCL) is an aggressive cancer with variable clinical response. Despite recent attempts by gene expression profiling to identify the dog as a potential animal model for human DLBCL, this tumor remains biologically heterogeneous with no prognostic biomarkers to predict prognosis. The aim of this work was to identify copy number aberrations (CNAs) by high-resolution array comparative genomic hybridization (aCGH) in 12 dogs with newly diagnosed DLBCL. In a subset of these dogs, the genetic profiles at the end of therapy and at relapse were also assessed. In primary DLBCLs, 90 different genomic imbalances were counted, consisting of 46 gains and 44 losses. Two gains in chr13 were significantly correlated with clinical stage. In addition, specific regions of gains and losses were significantly associated to duration of remission. In primary DLBCLs, individual variability was found, however 14 recurrent CNAs (>30%) were identified. Losses involving IGK, IGL and IGH were always found, and gains along the length of chr13 and chr31 were often observed (>41%). In these segments, MYC, LDHB, HSF1, KIT and PDGFRα are annotated. At the end of therapy, dogs in remission showed four new CNAs, whereas three new CNAs were observed in dogs at relapse compared with the previous profiles. One ex novo CNA, involving TCR, was present in dogs in remission after therapy, possibly induced by the autologous vaccine. Overall, aCGH identified small CNAs associated with outcome, which, along with future expression studies, may reveal target genes relevant to cDLBCL.Arianna AricòSerena FerraressoSilvia BresolinLaura MarconatoStefano ComazziGeertruy Te KronnieLuca AresuPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 11, p e111817 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Arianna Aricò
Serena Ferraresso
Silvia Bresolin
Laura Marconato
Stefano Comazzi
Geertruy Te Kronnie
Luca Aresu
Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
description Canine Diffuse Large B-cell Lymphoma (cDLBCL) is an aggressive cancer with variable clinical response. Despite recent attempts by gene expression profiling to identify the dog as a potential animal model for human DLBCL, this tumor remains biologically heterogeneous with no prognostic biomarkers to predict prognosis. The aim of this work was to identify copy number aberrations (CNAs) by high-resolution array comparative genomic hybridization (aCGH) in 12 dogs with newly diagnosed DLBCL. In a subset of these dogs, the genetic profiles at the end of therapy and at relapse were also assessed. In primary DLBCLs, 90 different genomic imbalances were counted, consisting of 46 gains and 44 losses. Two gains in chr13 were significantly correlated with clinical stage. In addition, specific regions of gains and losses were significantly associated to duration of remission. In primary DLBCLs, individual variability was found, however 14 recurrent CNAs (>30%) were identified. Losses involving IGK, IGL and IGH were always found, and gains along the length of chr13 and chr31 were often observed (>41%). In these segments, MYC, LDHB, HSF1, KIT and PDGFRα are annotated. At the end of therapy, dogs in remission showed four new CNAs, whereas three new CNAs were observed in dogs at relapse compared with the previous profiles. One ex novo CNA, involving TCR, was present in dogs in remission after therapy, possibly induced by the autologous vaccine. Overall, aCGH identified small CNAs associated with outcome, which, along with future expression studies, may reveal target genes relevant to cDLBCL.
format article
author Arianna Aricò
Serena Ferraresso
Silvia Bresolin
Laura Marconato
Stefano Comazzi
Geertruy Te Kronnie
Luca Aresu
author_facet Arianna Aricò
Serena Ferraresso
Silvia Bresolin
Laura Marconato
Stefano Comazzi
Geertruy Te Kronnie
Luca Aresu
author_sort Arianna Aricò
title Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
title_short Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
title_full Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
title_fullStr Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
title_full_unstemmed Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.
title_sort array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large b-cell lymphoma.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/c69288cf336e43e3a27944a281b0616b
work_keys_str_mv AT ariannaarico arraybasedcomparativegenomichybridizationanalysisrevealschromosomalcopynumberaberrationsassociatedwithclinicaloutcomeincaninediffuselargebcelllymphoma
AT serenaferraresso arraybasedcomparativegenomichybridizationanalysisrevealschromosomalcopynumberaberrationsassociatedwithclinicaloutcomeincaninediffuselargebcelllymphoma
AT silviabresolin arraybasedcomparativegenomichybridizationanalysisrevealschromosomalcopynumberaberrationsassociatedwithclinicaloutcomeincaninediffuselargebcelllymphoma
AT lauramarconato arraybasedcomparativegenomichybridizationanalysisrevealschromosomalcopynumberaberrationsassociatedwithclinicaloutcomeincaninediffuselargebcelllymphoma
AT stefanocomazzi arraybasedcomparativegenomichybridizationanalysisrevealschromosomalcopynumberaberrationsassociatedwithclinicaloutcomeincaninediffuselargebcelllymphoma
AT geertruytekronnie arraybasedcomparativegenomichybridizationanalysisrevealschromosomalcopynumberaberrationsassociatedwithclinicaloutcomeincaninediffuselargebcelllymphoma
AT lucaaresu arraybasedcomparativegenomichybridizationanalysisrevealschromosomalcopynumberaberrationsassociatedwithclinicaloutcomeincaninediffuselargebcelllymphoma
_version_ 1718414425461882880